Literature DB >> 28456449

Incidence of salivary side effects after radioiodine treatment using a new specifically-designed questionnaire.

E Moreddu1, K Baumstarck-Barrau2, S Gabriel3, N Fakhry4, F Sebag5, O Mundler3, C Chossegros6, D Taïeb3.   

Abstract

Sialadenitis is one of the common complications of radioiodine treatment for thyroid malignancy. The aim of this study was to evaluate the prevalence of radioiodine-induced sialadenitis and other side effects by using a self-administered questionnaire. From 1 January 2011 to 31 December 2012 all consecutive patients with a newly-established diagnosis of thyroid cancer who were treated with adjuvant radioiodine at La Timone University Hospital were sent a self-administered questionnaire on salivary complaints that had been specifically designed for this study. A total of 413 patients sent the questionnaire back, of whom 100 (24%) had experienced pain, 116 (28%) discomfort or swelling, and 147 (36%) dry mouth or xerostomia. This survey has highlighted the number of side effects of radioiodine treatment in a large group of patients and corroborates previous observations. Our new self-administered questionnaire may be useful to others for follow-up and research.
Copyright © 2017 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  radioiodine; recombinant Human TSH; salivary; sialadenitis; thyroid neoplasm

Mesh:

Substances:

Year:  2017        PMID: 28456449     DOI: 10.1016/j.bjoms.2017.03.019

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  1 in total

1.  Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study).

Authors:  Clémence Baudin; Charlotte Lussey-Lepoutre; Alice Bressand; Camille Buffet; Fabrice Menegaux; Marine Soret; David Broggio; Céline Bassinet; Christelle Huet; Gemma Armengol; Laurence Leenhardt; Marie-Odile Bernier
Journal:  JMIR Res Protoc       Date:  2022-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.